ONL Therapeutics

Excited to share that our CEO David Esposito will be speaking at the 2nd Annual Leading to Win Summit in Austin, Texas, on Sept. 13! David will join David Ottavianelli from John Deere and Benedict Chu with Amgen for a Fireside Chat on "Boots to Business: The Military to Civilian Transition." This session will include insights on various career paths and crucial skills to help veterans succeed in the civilian workplace. The Leading to Win Summit brings together stakeholders from academia, industry, government and the veteran community to explore the opportunities and challenges of the CHIPS Act in driving defense innovation, entrepreneurship and workforce development in Texas, while supporting national security priorities and fostering a strong, inclusive ecosystem for growth and collaboration. Thank you to our moderator, IBM’s Jason Kelley for your tremendous leadership and support for our military community. ONL is proud to contribute to this important conversation supporting our military community's career development. Learn more: https://lnkd.in/eFwTywDq #LeadingToWin2024 #VeteranWorkforce #ONLTherapeutics

Our team is off to Europe next week for back-to-back conferences starting with The Retina Society's 57th Annual Scientific Meeting in Lisbon, Portugal. If you're attending, pay us a visit at Booth 14 to learn about Fas inhibition with ONL1204 for the potential treatment of geographic atrophy. #RetinaSociety2024 #RetinaInnovation #Neuroprotection #ONL1204

Curious about our Phase 2 RRD trial? Join our COO Connie Chang for an illuminating discussion on ONL’s pioneering approach to protect and improve the vision of patients. #RetinaInnovation #RetinalDetachment  #RRD

Kudos to our VP of Clinical Affairs Lori H. for her poster presentation on "Fas Inhibition with ONL1204 for the Potential Treatment of Geographic Atrophy: Phase 1b Study Results" at the Women in Ophthalmology Summer Symposium. The audience response was positive, with engaging questions and discussions. Thanks to all who stopped by to learn about our groundbreaking clinical research! Missed us at the symposium? We're always open to connecting and sharing our unique and differentiated mechanism of action of Fas inhibition implicated in multiple eye diseases. #WIO2024 #WomenInOphthalmology #RetinaInnovation #GeographicAtrophy

Great to be here at WIO with Lori H. and David Esposito - looking forward to connecting with the ophthalmology community at the meeting! https://lnkd.in/ekc5xbfC

As summer comes to a close, we bid farewell to our amazing interns who've made a lasting impact here at ONL Therapeutics. A heartfelt thank you to (pictured L-R): • Brian Valladares (Research) – PhD Candidate, Organic Chemistry, University of Michigan • Sreeja Konatham (Clinical Operations) - MS Candidate, Clinical Research Administration, Eastern Michigan University • Katerina Kornievskaia (Clinical Affairs) - PharmD Candidate, University of Michigan Your fresh perspectives, hard work, and capstone projects have been invaluable - you'll always be part of the ONL family. Best of luck in your studies and future careers! And to our full-time team, thank you for your mentorship. You've played a crucial role in making our internship program a success. #Internship #FutureLeaders #ONLCareers

Attending the Women in Ophthalmology Summer Symposium? Be sure to check out ONL's poster session presented by our VP of Clinical Affairs Lori H. on Saturday, August 24 at 11:05 am (local time)! #WIO2024 #WomenInOphthalmology #RetinaInnovation #GeographicAtrophy

Our team is gearing up for the Women in Ophthalmology Summer Symposium next week in California, with an action-packed schedule. We invite you to learn more about our unique mechanism of action (MOA) of Fas inhibition implicated in multiple eye diseases. Let’s connect: ☑ Visit us at Booth T36 in the exhibit hall ☑ Attend our Professional Development Sponsorship, Breakout I: Inspirations for the Next Move, Friday, Aug. 23, 11:05 am – 11:50 am ☑ Check out our poster session: Session 1, Monitor 17, Saturday, Aug. 24, 11:05 am - 11:50 am We're excited to connect with researchers, clinicians and industry leaders in ophthalmology to help patients see the future! #WIO2024 #WomenInOphthalmology #RetinaInnovation #ONLTherapeutics #Neuroprotection

Join us for an exclusive webinar on September 10 featuring ONL Therapeutics as they share insights into their Phase 2 RRD program and experiences partnering with a specialized CRO-integrated reading center. Hear from industry leaders Connie Chang, Daniel Russakoff and Sally Tucker, PhD, you don't want to miss it! Register here: https://lnkd.in/gCkNdgm6 #clinicalresearch #ophthalmology #innovation #webinar #readingcenter #Lexitas